APAC Gastric Cancer Diagnostics Market - Industry Trends and Forecast to 2030
Description
APAC Gastric Cancer Diagnostics Market - Industry Trends and Forecast to 2030
Asia-Pacific gastric cancer diagnostics market is projected to register a CAGR of 10.0% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030.
Market Segmentation:
Asia-Pacific Gastric Cancer Diagnostics Market, By Product Type (Instruments, Reagents & Consumables, Services), Diagnostics Type (Gastric (Pre) Cancer Screening Tests/Physical Exam, Confirmatory Tests), Age Group (Adult, Pediatric, and Geriatrics), Type (Intestinal Or Diffuse Adenocarcinoma, Carcinoid Tumor, Gastrointestinal Stromal Tumor (GIST), Gastric Lymphoma and Others), Stage (Stage 0, Stage I, Stage II, Stage III), Gender (Male and Female), Sample Type (Blood, Tissue, Urine, and Stool), End Users (Diagnostic Laboratories, Hospitals, Cancer Research Institutes, Oncology Specialty Clinics, and Others), Distribution Channel (Direct Tenders and Retail Sales), Country ( Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest of Asia-Pacific) Industry Trends and Forecast To 2030
Some of the major factors contributing to the growth of the Asia-Pacific gastric cancer diagnostics market are:
• Rising healthcare expenditure for better health services
• Increase in diagnostic procedures for gastric cancer
• Growing prevalence of gastric cancer
Market Players:
Some of the key market players in the Asia-Pacific gastric cancer diagnostics market are listed below:
• BIOMÉRIEUX
• Myriad Genetics, Inc.
• ACON Laboratories, Inc.
• Vela Diagnostics
• Abbott
• AdvaCare Pharma
• MiRXES
• Fujirebio ( An H.U. Group company)
• Thermo Fisher Scientific Inc.
• F. Hoffmann-La Roche Ltd
• GENERAL ELECTRIC COMPANY
• Agilent Technologies, Inc.
• Endofotonics Pte Ltd
• Biohit Oyj
• DiaSorin S.p.A
• Paragon Genomics, Inc.
• QIAGEN
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Asia-Pacific gastric cancer diagnostics market is projected to register a CAGR of 10.0% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030.
Market Segmentation:
Asia-Pacific Gastric Cancer Diagnostics Market, By Product Type (Instruments, Reagents & Consumables, Services), Diagnostics Type (Gastric (Pre) Cancer Screening Tests/Physical Exam, Confirmatory Tests), Age Group (Adult, Pediatric, and Geriatrics), Type (Intestinal Or Diffuse Adenocarcinoma, Carcinoid Tumor, Gastrointestinal Stromal Tumor (GIST), Gastric Lymphoma and Others), Stage (Stage 0, Stage I, Stage II, Stage III), Gender (Male and Female), Sample Type (Blood, Tissue, Urine, and Stool), End Users (Diagnostic Laboratories, Hospitals, Cancer Research Institutes, Oncology Specialty Clinics, and Others), Distribution Channel (Direct Tenders and Retail Sales), Country ( Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest of Asia-Pacific) Industry Trends and Forecast To 2030
Some of the major factors contributing to the growth of the Asia-Pacific gastric cancer diagnostics market are:
• Rising healthcare expenditure for better health services
• Increase in diagnostic procedures for gastric cancer
• Growing prevalence of gastric cancer
Market Players:
Some of the key market players in the Asia-Pacific gastric cancer diagnostics market are listed below:
• BIOMÉRIEUX
• Myriad Genetics, Inc.
• ACON Laboratories, Inc.
• Vela Diagnostics
• Abbott
• AdvaCare Pharma
• MiRXES
• Fujirebio ( An H.U. Group company)
• Thermo Fisher Scientific Inc.
• F. Hoffmann-La Roche Ltd
• GENERAL ELECTRIC COMPANY
• Agilent Technologies, Inc.
• Endofotonics Pte Ltd
• Biohit Oyj
• DiaSorin S.p.A
• Paragon Genomics, Inc.
• QIAGEN
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Table of Contents
262 Pages
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of The Asia Pacific Gastric Cancer Diagnostics Market
- 1.4 Limitations
- 1.5 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Currency And Pricing
- 2.5 Dbmr Tripod Data Validation Model
- 2.6 Multivariate Modelling
- 2.7 Product Type Lifeline Curve
- 2.8 Primary Interviews With Key Opinion Leaders
- 2.9 Dbmr Market Position Grid
- 2.10 Vendor Share Analysis
- 2.11 Market End Coverage Grid
- 2.12 Secondary Sources
- 2.13 Assumptions
- 3 Executive Summary
- 4 Premium Insight
- 4.1 Pestel's Model
- 4.2 Porter's 5 Forces
- 4.3 Epidemiology
- 4.4 Brand Analysis
- 4.5 Role Of Artificial Intelligence (Ai) And Machine Learning (Ml): Asia Pacific Gastric Cancer Diagnostics Market
- 4.6 Industry Insights:
- 5 Asia Pacific Gastric Cancer Diagnostics Market, Regulatory
- 5.1 Asia-pacific
- 5.1.1 Regulatory Scenario In Australia-
- 5.1.2 Regulatory Scenario In Japan
- 5.1.3 Regulatory Scenario In China
- 5.1.4 Regulatory Scenario In Singapore-
- 6 Market Overview
- 6.1 Drivers
- 6.1.1 Increase In Incidence Of Gastrointestinal Tumours, Lymphoma, And Adenocarcinoma
- 6.1.2 Rise In Alcohol Consumption And Surge In Smoking
- 6.1.3 Increase In The Geriatric Population
- 6.1.4 Recent Advancements In Gastric Cancer Diagnostics Products
- 6.2 Restraints
- 6.2.1 High Cost Of Gastric Cancer Diagnostic Test
- 6.2.2 Lack Of Sufficient Financial Support From Health Insurance Policies
- 6.3 Opportunities
- 6.3.1 Rise In The Adoption Of Automated Systems
- 6.3.2 Increased Research And Development On Cancer Diagnostics Products
- 6.3.3 Strategic Initiatives By Emerging Players
- 6.4 Challenges
- 6.4.1 Stringent Regulations And Policies For Approving The Complicated Nature Of Radiation Devices
- 6.4.2 Limitations Of Radiation Tests
- 7 Asia Pacific Gastric Cancer Diagnostics Market, By Product Type
- 7.1 Overview
- 7.2 Reagents & Consumables
- 7.2.1 Kits
- 7.2.1.1 Dna Polymerase Kits
- 7.2.1.2 Pcr Kits
- 7.2.1.3 Nucleic Acid Isolation Kits
- 7.2.1.4 Others
- 7.2.2 Reagents
- 7.2.2.1 Assays
- 7.2.2.2 Buffers
- 7.2.2.3 Primers
- 7.2.2.4 Others
- 7.3 Instruments
- 7.4 Services
- 8 Asia Pacific Gastric Cancer Diagnostics Market, By Diagnostic Type
- 8.1 Overview
- 8.2 Confirmatory Test
- 8.2.1 Imaging Tests
- 8.2.1.1 Pet Scan/Ct Scan
- 8.2.1.2 Ct Scan
- 8.2.1.3 Ultrasound
- 8.2.1.4 Mri
- 8.2.1.5 X-ray
- 8.2.2 Biomarker
- 8.2.2.1 Dna Biomarker
- 8.2.2.2 Rna Biomarker
- 8.2.2.3 Protein Biomarker
- 8.2.3 Biopsy
- 8.3 Gastric Cancer Screening Tests/Physical Exam
- 9 Asia Pacific Gastric Cancer Diagnostics Market, By Age Group
- 9.1 Overview
- 9.2 Geriatrics
- 9.3 Adult
- 9.4 Pediatric
- 10 Asia Pacific Gastric Cancer Diagnostics Market, By Disease Type
- 10.1 Overview
- 10.2 Intestinal Or Diffuse Adenocarcinoma
- 10.3 Carcinoid Tumor
- 10.4 Gastrointestinal Stromal Tumor
- 10.5 Gastric Lymphoma
- 10.6 Others
- 11 Asia Pacific Gastric Cancer Diagnostics Market, By Stage
- 11.1 Overview
- 11.2 Stage I
- 11.2.1 Stage Ia
- 11.2.2 Stage Ib
- 11.3 Stage Ii
- 11.3.1 Stage Iia
- 11.3.2 Stage Iib
- 11.4 Stage Iii
- 11.4.1 Stage Iiia
- 11.4.2 Stage Iiib
- 11.4.3 Stage Iiic
- 11.5 Stage 0
- 12 Asia Pacific Gastric Cancer Diagnostics Market, By Gender
- 12.1 Overview
- 12.2 Male
- 12.3 Female
- 13 Asia Pacific Gastric Cancer Diagnostics Market, By Sample Type
- 13.1 Overview
- 13.2 Stool
- 13.3 Tissue
- 13.4 Blood
- 13.5 Urine
- 14 Asia Pacific Gastric Cancer Diagnostics Market, By End User
- 14.1 Overview
- 14.2 Hospitals
- 14.3 Diagnostic Laboratories
- 14.4 Cancer Research Institutes
- 14.5 Oncology Specialty Clinics
- 14.6 Others
- 15 Asia Pacific Gastric Cancer Diagnostics Market, By Distribution Channel
- 15.1 Overview
- 15.2 Direct Tenders
- 15.3 Retail Sales
- 16 Asia Pacific Gastric Cancer Diagnostics Market, By Region
- 16.1 Asia-pacific
- 16.1.1 South Korea
- 16.1.2 Japan
- 16.1.3 China
- 16.1.4 Australia
- 16.1.5 Singapore
- 16.1.6 India
- 16.1.7 Thailand
- 16.1.8 Malaysia
- 16.1.9 Indonesia
- 16.1.10 Philippines
- 16.1.11 Rest Of Asia-pacific
- 17 Asia Pacific Gastric Cancer Diagnostics Market, Company Landscape
- 17.1 Company Share Analysis: Asia Pacific
- 18 Swot Analysis
- 19 Company Profile
- 19.1 F. Hoffmann-la Roche Ltd
- 19.1.1 Company Snapshot
- 19.1.2 Revenue Analysis
- 19.1.3 Company Share Analysis
- 19.1.4 Product Portfolio
- 19.1.5 Recent Development
- 19.2 General Electric
- 19.2.1 Company Snapshot
- 19.2.2 Revenue Analysis
- 19.2.3 Company Share Analysis
- 19.2.4 Product Portfolio
- 19.2.5 Recent Development
- 19.3 Abbott
- 19.3.1 Company Snapshot
- 19.3.2 Revenue Analysis
- 19.3.3 Company Share Analysis
- 19.3.4 Product Portfolio
- 19.3.5 Recent Development
- 19.4 Qiagen
- 19.4.1 Company Snapshot
- 19.4.2 Revenue Analysis
- 19.4.3 Company Share Analysis
- 19.4.4 Product Portfolio
- 19.4.5 Recent Development
- 19.5 Myriad Genetics, Inc.
- 19.5.1 Company Snapshot
- 19.5.2 Revenue Analysis
- 19.5.3 Company Share Analysis
- 19.5.4 Product Portfolio
- 19.5.5 Recent Development
- 19.6 Acon Laboratories, Inc.
- 19.6.1 Company Snapshot
- 19.6.2 Product Portfolio
- 19.6.3 Recent Development
- 19.7 Advacare Pharma
- 19.7.1 Company Snapshot
- 19.7.2 Product Portfolio
- 19.7.3 Recent Development
- 19.8 Agilent Technologies, Inc.
- 19.8.1 Company Snapshot
- 19.8.2 Revenue Analysis
- 19.8.3 Product Portfolio
- 19.8.4 Recent Developments
- 19.9 Biomérieux
- 19.9.1 Company Snapshot
- 19.9.2 Revenue Analysis
- 19.9.3 Product Portfolio
- 19.9.4 Recent Development
- 19.10 Biocept, Inc.
- 19.10.1 Company Snapshot
- 19.10.2 Revenue Analysis
- 19.10.3 Product Portfolio
- 19.10.4 Recent Development
- 19.11 Biohit Oyj
- 19.11.1 Company Snapshot
- 19.11.2 Revenue Analysis
- 19.11.3 Product Portfolio
- 19.11.4 Recent Development
- 19.12 Diasorin S.P.A
- 19.12.1 Company Snapshot
- 19.12.2 Revenue Analysis
- 19.12.3 Product Portfolio
- 19.12.4 Recent Development
- 19.13 Endofotonics Pte Ltd
- 19.13.1 Company Snapshot
- 19.13.2 Product Portfolio
- 19.13.3 Recent Development
- 19.14 Foundation Medicine, Inc.
- 19.14.1 Company Snapshot
- 19.14.2 Product Portfolio
- 19.14.3 Recent Developments
- 19.15 Fujirebio (An H.U. Group Company)
- 19.15.1 Company Snapshot
- 19.15.2 Revenue Analysis
- 19.15.3 Product Portfolio
- 19.15.4 Recent Development
- 19.16 Mirxes Pte Ltd.
- 19.16.1 Company Snapshot
- 19.16.2 Product Portfolio
- 19.16.3 Recent Development
- 19.17 Paragon Genomics, Inc.
- 19.17.1 Company Snapshot
- 19.17.2 Product Portfolio
- 19.17.3 Recent Developments
- 19.18 Teco Diagnostics
- 19.18.1 Company Snapshot
- 19.18.2 Product Portfolio
- 19.18.3 Recent Development
- 19.19 Thermo Fisher Scientific Inc.
- 19.19.1 Company Snapshot
- 19.19.2 Revenue Analysis
- 19.19.3 Product Portfolio
- 19.19.4 Recent Developments
- 19.20 Vela Diagnostics
- 19.20.1 Company Snapshot
- 19.20.2 Product Portfolio
- 19.20.3 Recent Developments
- 20 Questionnaire
- 21 Related Reports 262
- List Of Tables
- Table 1 Approved Companion Diagnostic Device
- Table 2 The Below-mentioned List Shows The Cost Of Pet Scan For Cancer Diagnosis In Different Regions Across The Globe-
- Table 3 Asia Pacific Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 4 Asia Pacific Reagents & Consumables In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 5 Asia Pacific Reagent And Consumables In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 6 Asia Pacific Kits In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 7 Asia Pacific Reagents In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 8 Asia Pacific Instruments In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 9 Asia Pacific Services In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 10 Asia Pacific Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 11 Asia Pacific Confirmatory Test In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 12 Asia Pacific Confirmatory Test In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 13 Asia Pacific Imaging Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 14 Asia Pacific Biomarker In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 15 Asia Pacific Gastric Cancer Screening Tests/Physical Exam In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 16 Asia Pacific Gastric Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 17 Asia Pacific Geriatrics In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 18 Asia Pacific Adult In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 19 Asia Pacific Pediatric In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 20 Asia Pacific Gastric Cancer Diagnostics Market, By Disease Type, 2021-2030 (Usd Million)
- Table 21 Asia Pacific Intestinal Or Diffuse Adenocarcinoma In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 22 Asia Pacific Carcinoid Tumor In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 23 Asia Pacific Gastrointestinal Stromal Tumor In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 24 Asia Pacific Gastric Lymphoma In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 25 Asia Pacific Others In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 26 Asia Pacific Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 27 Asia Pacific Stage I In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 28 Asia Pacific Stage I In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 29 Asia Pacific Stage Ii In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 30 Asia Pacific Stage Ii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 31 Asia Pacific Stage Iii In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 32 Asia Pacific Stage Iii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 33 Asia Pacific Stage 0 In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 34 Asia Pacific Gastric Cancer Diagnostics Market, By Gender, 2021-2030 (Usd Million)
- Table 35 Asia Pacific Male In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 36 Asia Pacific Female In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 37 Asia Pacific Gastric Cancer Diagnostics Market, By Sample Type, 2021-2030 (Usd Million)
- Table 38 Asia Pacific Stool In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 39 Asia Pacific Tissue In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 40 Asia Pacific Blood In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 41 Asia Pacific Urine In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 42 Asia Pacific Gastric Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
- Table 43 Asia Pacific Hospitals In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 44 Asia Pacific Diagnostic Laboratories In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 45 Asia Pacific Cancer Research Institutes In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 46 Asia Pacific Oncology Specialty Clinics In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 47 Asia Pacific Others In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 48 Asia Pacific Gastric Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 49 Asia Pacific Direct Tenders In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 50 Asia Pacific Retail Sales In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 51 Asia-pacific Gastric Cancer Diagnostics Market, By Country, 2021-2030 (Usd Million)
- Table 52 Asia-pacific Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 53 Asia-pacific Reagents & Consumables In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 54 Asia-pacific Kits In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 55 Asia-pacific Reagents In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 56 Asia-pacific Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 57 Asia-pacific Confirmatory Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 58 Asia-pacific Biomarker In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 59 Asia-pacific Gastric Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 60 Asia-pacific Gastric Cancer Diagnostics Market, By Disease Type, 2021-2030 (Usd Million)
- Table 61 Asia-pacific Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 62 Asia-pacific Stage I In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 63 Asia-pacific Stage Ii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 64 Asia-pacific Stage Iii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 65 Asia-pacific Gastric Cancer Diagnostics Market, By Gender, 2021-2030 (Usd Million)
- Table 66 Asia-pacific Gastric Cancer Diagnostics Market, By Sample Type, 2021-2030 (Usd Million)
- Table 67 Asia-pacific Gastric Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
- Table 68 Asia-pacific Gastric Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 69 South Korea Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 70 South Korea Reagents & Consumables In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 71 South Korea Kits In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 72 South Korea Reagents In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 73 South Korea Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 74 South Korea Confirmatory Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 75 South Korea Imaging Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 76 South Korea Biomarker In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 77 South Korea Gastric Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 78 South Korea Gastric Cancer Diagnostics Market, By Disease Type, 2021-2030 (Usd Million)
- Table 79 South Korea Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 80 South Korea Stage I In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 81 South Korea Stage Ii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 82 South Korea Stage Iii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 83 South Korea Gastric Cancer Diagnostics Market, By Gender, 2021-2030 (Usd Million)
- Table 84 South Korea Gastric Cancer Diagnostics Market, By Sample Type, 2021-2030 (Usd Million)
- Table 85 South Korea Gastric Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
- Table 86 South Korea Gastric Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 87 Japan Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 88 Japan Reagents & Consumables In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 89 Japan Kits In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 90 Japan Reagents In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 91 Japan Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 92 Japan Confirmatory Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 93 Japan Imaging Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 94 Japan Biomarker In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 95 Japan Gastric Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 96 Japan Gastric Cancer Diagnostics Market, By Disease Type, 2021-2030 (Usd Million)
- Table 97 Japan Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 98 Japan Stage I In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 99 Japan Stage Ii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 100 Japan Stage Iii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 101 Japan Gastric Cancer Diagnostics Market, By Gender, 2021-2030 (Usd Million)
- Table 102 Japan Gastric Cancer Diagnostics Market, By Sample Type, 2021-2030 (Usd Million)
- Table 103 Japan Gastric Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
- Table 104 Japan Gastric Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 105 China Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 106 China Reagents & Consumables In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 107 China Kits In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 108 China Reagents In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 109 China Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 110 China Confirmatory Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 111 China Imaging Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 112 China Biomarker In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 113 China Gastric Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 114 China Gastric Cancer Diagnostics Market, By Disease Type, 2021-2030 (Usd Million)
- Table 115 China Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 116 China Stage I In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 117 China Stage Ii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 118 China Stage Iii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 119 China Gastric Cancer Diagnostics Market, By Gender, 2021-2030 (Usd Million)
- Table 120 China Gastric Cancer Diagnostics Market, By Sample Type, 2021-2030 (Usd Million)
- Table 121 China Gastric Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
- Table 122 China Gastric Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 123 Australia Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 124 Australia Reagents & Consumables In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 125 Australia Kits In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 126 Australia Reagents In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 127 Australia Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 128 Australia Confirmatory Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 129 Australia Imaging Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 130 Australia Biomarker In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 131 Australia Gastric Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 132 Australia Gastric Cancer Diagnostics Market, By Disease Type, 2021-2030 (Usd Million)
- Table 133 Australia Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 134 Australia Stage I In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 135 Australia Stage Ii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 136 Australia Stage Iii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 137 Australia Gastric Cancer Diagnostics Market, By Gender, 2021-2030 (Usd Million)
- Table 138 Australia Gastric Cancer Diagnostics Market, By Sample Type, 2021-2030 (Usd Million)
- Table 139 Australia Gastric Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
- Table 140 Australia Gastric Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 141 Singapore Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 142 Singapore Reagents & Consumables In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 143 Singapore Kits In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 144 Singapore Reagents In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 145 Singapore Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 146 Singapore Confirmatory Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 147 Singapore Imaging Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 148 Singapore Biomarker In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 149 Singapore Gastric Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- List Of Figures
- Figure 1 Asia Pacific Gastric Cancer Diagnostics Market: Segmentation
- Figure 2 Asia Pacific Gastric Cancer Diagnostics Market: Data Triangulation
- Figure 3 Asia Pacific Gastric Cancer Diagnostics Market: Droc Analysis
- Figure 4 Asia Pacific Gastric Cancer Diagnostics Market: Asia Pacific Vs. Regional Market Analysis
- Figure 5 Asia Pacific Gastric Cancer Diagnostics Market: Company Research Analysis
- Figure 6 Asia Pacific Gastric Cancer Diagnostics Market: Multivariate Modelling
- Figure 7 Asia Pacific Gastric Cancer Diagnostics Market: Interview Demographics
- Figure 8 Asia Pacific Gastric Cancer Diagnostics Market: Dbmr Market Position Grid
- Figure 9 Asia Pacific Gastric Cancer Diagnostics Market: Vendor Share Analysis
- Figure 10 Asia Pacific Gastric Cancer Diagnostics Market: Market End Coverage Grid
- Figure 11 Asia Pacific Gastric Cancer Diagnostics Market: Segmentation
- Figure 12 Increase In The Incidence Of Gastrointestinal Tumors, Lymphoma, And Adenocarcinoma Is Expected To Drive The Asia Pacific Gastric Cancer Diagnostics Market Growth In The Forecast Period Of 2023 To 2030
- Figure 13 Reagents And Consumables Segment Is Expected To Account For The Largest Share Of The Asia Pacific Gastric Cancer Diagnostics Market In 2023 & 2030
- Figure 14 Drivers, Restraints, Opportunities, And Challenges, Of The Asia Pacific Gastric Cancer Diagnostics Market
- Figure 15 Asia Pacific Gastric Cancer Diagnostics Market: By Product Type, 2022
- Figure 16 Asia Pacific Gastric Cancer Diagnostics Market: By Product Type, 2023-2030 (Usd Million)
- Figure 17 Asia Pacific Gastric Cancer Diagnostics Market: By Product Type, Cagr (2023-2030)
- Figure 18 Asia Pacific Gastric Cancer Diagnostics Market: By Product Type, Lifeline Curve
- Figure 19 Asia Pacific Gastric Cancer Diagnostics Market: By Diagnostic Type, 2022
- Figure 20 Asia Pacific Gastric Cancer Diagnostics Market: By Diagnostic Type, 2023-2030 (Usd Million)
- Figure 21 Asia Pacific Gastric Cancer Diagnostics Market: By Diagnostic Type, Cagr (2023-2030)
- Figure 22 Asia Pacific Gastric Cancer Diagnostics Market: By Diagnostic Type, Lifeline Curve
- Figure 23 Asia Pacific Gastric Cancer Diagnostics Market: By Age Group, 2022
- Figure 24 Asia Pacific Gastric Cancer Diagnostics Market: By Age Group, 2023-2030 (Usd Million)
- Figure 25 Asia Pacific Gastric Cancer Diagnostics Market: By Age Group, Cagr (2023-2030)
- Figure 26 Asia Pacific Gastric Cancer Diagnostics Market: By Age Group, Lifeline Curve
- Figure 27 Asia Pacific Gastric Cancer Diagnostics Market: By Disease Type, 2022
- Figure 28 Asia Pacific Gastric Cancer Diagnostics Market: By Disease Type, 2023-2030 (Usd Million)
- Figure 29 Asia Pacific Gastric Cancer Diagnostics Market: By Disease Type, Cagr (2023-2030)
- Figure 30 Asia Pacific Gastric Cancer Diagnostics Market: By Disease Type, Lifeline Curve
- Figure 31 Asia Pacific Gastric Cancer Diagnostics Market: By Stage, 2022
- Figure 32 Asia Pacific Gastric Cancer Diagnostics Market: By Stage, 2023-2030 (Usd Million)
- Figure 33 Asia Pacific Gastric Cancer Diagnostics Market: By Stage, Cagr (2023-2030)
- Figure 34 Asia Pacific Gastric Cancer Diagnostics Market: By Stage, Lifeline Curve
- Figure 35 Asia Pacific Gastric Cancer Diagnostics Market: By Gender, 2022
- Figure 36 Asia Pacific Gastric Cancer Diagnostics Market: By Gender, 2023-2030 (Usd Million)
- Figure 37 Asia Pacific Gastric Cancer Diagnostics Market: By Gender, Cagr (2023-2030)
- Figure 38 Asia Pacific Gastric Cancer Diagnostics Market: By Gender, Lifeline Curve
- Figure 39 Asia Pacific Gastric Cancer Diagnostics Market: By Sample Type, 2022
- Figure 40 Asia Pacific Gastric Cancer Diagnostics Market: By Sample Type, 2023-2030 (Usd Million)
- Figure 41 Asia Pacific Gastric Cancer Diagnostics Market: By Sample Type, Cagr (2023-2030)
- Figure 42 Asia Pacific Gastric Cancer Diagnostics Market: By Sample Type, Lifeline Curve
- Figure 43 Asia Pacific Gastric Cancer Diagnostics Market: By End User, 2022
- Figure 44 Asia Pacific Gastric Cancer Diagnostics Market: By End User, 2023-2030 (Usd Million)
- Figure 45 Asia Pacific Gastric Cancer Diagnostics Market: By End User, Cagr (2023-2030)
- Figure 46 Asia Pacific Gastric Cancer Diagnostics Market: By End User, Lifeline Curve
- Figure 47 Asia Pacific Gastric Cancer Diagnostics Mark
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
